Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin (Q34271895)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

author name string

Remberger M

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Aschan J

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Barkholt L

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Tollemar J

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Ringdén O

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 2001

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Clinical Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

147-153

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Dysregulation of cytokines during graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

21 January 2018

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

21 January 2018

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

21 January 2018

Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide for graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological reconstitution following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Recovery of in vivo cellular immunity after human marrow grafting. Influence of time postgrafting and acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

PCR and other non-culture methods for diagnosis of invasive Candida infections in allogeneic bone marrow and solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150301.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1399-0012.2001.150301.X

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34271895&oldid=2041854518"